Mauna Kea's optical biopsy miniprobe gets FDA OK

05/6/2013 | MassDevice.com (Boston)

Mauna Kea Technologies secured 510(k) clearance from the FDA and can now market its AQ-Flex 19 system, an optical biopsy miniprobe used to examine pancreatic cysts in patients undergoing endoscopic needle aspiration procedures in the digestive tract.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN